These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7947932)

  • 1. The purification and partial characterization of bone resorptive polypeptides from bovine bone matrix.
    Hill PA; Reynolds JJ; Meikle MC
    Biochim Biophys Acta; 1994 Nov; 1201(2):193-202. PubMed ID: 7947932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast recruiting activity in bone matrix.
    Hentunen TA; Cunningham NS; Vuolteenaho O; Reddi AH; Väänänen HK
    Bone Miner; 1994 Jun; 25(3):183-98. PubMed ID: 8086857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins.
    Jennings JC; Mohan S
    Endocrinology; 1990 Feb; 126(2):1014-21. PubMed ID: 2137079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of bone morphogenetic protein derived from bovine bone matrix.
    Shibahara T; Noma H; Yama M; Ozawa Y; Yajima Y
    Bull Tokyo Dent Coll; 1995 May; 36(2):75-82. PubMed ID: 8689746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA; Tumber A; Papaioannou S; Meikle MC
    Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purification and characterization of a growth factor from human bone matrix].
    Suzuki K
    Nihon Seikeigeka Gakkai Zasshi; 1990 Oct; 64(10):928-36. PubMed ID: 2266301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of bone morphogenetic protein (BMP) derived from human and bovine bone matrix.
    Bessho K; Tagawa T; Murata M
    Clin Orthop Relat Res; 1991 Jul; (268):226-34. PubMed ID: 2060214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts.
    Oreffo RO; Bonewald L; Kukita A; Garrett IR; Seyedin SM; Rosen D; Mundy GR
    Endocrinology; 1990 Jun; 126(6):3069-75. PubMed ID: 1693566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.
    Chenu C; Pfeilschifter J; Mundy GR; Roodman GD
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5683-7. PubMed ID: 3165196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and solubility of bone morphogenetic protein derived from porcine bone matrix.
    Bessho K; Iizuka T
    Br J Oral Maxillofac Surg; 1994 Apr; 32(2):86-90. PubMed ID: 8199154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial purification and characterization of bone-resorbing factor from bovine bone matrix].
    Mori M
    Kokubyo Gakkai Zasshi; 1991 Mar; 58(1):155-68. PubMed ID: 2066624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.